CHRISTINA POLETE: Open Payments
NPI 1811305915 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 59 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $726 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $245 |
| AstraZeneca Pharmaceuticals LP | 3 | $163 |
| Phathom Pharmaceuticals, Inc. | 19 | $112 |
| Astellas Pharma US Inc | 2 | $74 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: BREZTRI, VOQUEZNA, VRAYLAR, UBRELVY, Veozah, QULIPTA, CAPLYTA, Auvelity.
Industry payments across KY — which companies pay providers there.
